Swiss National Bank lifted its holdings in R1 RCM Inc (NASDAQ:RCM) by 2.1% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 164,100 shares of the financial services provider’s stock after buying an additional 3,400 shares during the period. Swiss National Bank’s holdings in R1 RCM were worth $2,064,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Quantamental Technologies LLC purchased a new position in R1 RCM in the first quarter valued at approximately $67,000. Aperio Group LLC purchased a new position in R1 RCM in the second quarter valued at approximately $127,000. Los Angeles Capital Management & Equity Research Inc. purchased a new position in R1 RCM in the second quarter valued at approximately $139,000. SG Americas Securities LLC purchased a new position in R1 RCM in the first quarter valued at approximately $142,000. Finally, Ibex Investors LLC purchased a new position in R1 RCM in the second quarter valued at approximately $229,000. Hedge funds and other institutional investors own 70.20% of the company’s stock.
Several equities analysts recently commented on the company. BidaskClub downgraded R1 RCM from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 28th. Zacks Investment Research downgraded R1 RCM from a “buy” rating to a “hold” rating in a research note on Tuesday, August 13th. Finally, ValuEngine upgraded R1 RCM from a “buy” rating to a “strong-buy” rating in a research note on Wednesday. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $14.25.
Shares of R1 RCM stock traded up $0.03 during trading on Friday, hitting $11.28. The stock had a trading volume of 2,895 shares, compared to its average volume of 677,634. The firm has a market cap of $1.27 billion, a price-to-earnings ratio of -35.34 and a beta of 0.15. R1 RCM Inc has a 12 month low of $7.10 and a 12 month high of $13.19. The business’s 50-day moving average is $12.20 and its 200 day moving average is $11.34. The company has a current ratio of 0.90, a quick ratio of 0.90 and a debt-to-equity ratio of 106.30.
R1 RCM (NASDAQ:RCM) last released its quarterly earnings results on Tuesday, August 6th. The financial services provider reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The firm had revenue of $295.00 million during the quarter, compared to the consensus estimate of $294.11 million. R1 RCM had a negative return on equity of 249.01% and a negative net margin of 2.22%. The company’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.07) EPS. As a group, equities analysts expect that R1 RCM Inc will post -0.01 EPS for the current year.
R1 RCM Profile
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Featured Story: How to Invest in Growth Stocks
Want to see what other hedge funds are holding RCM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for R1 RCM Inc (NASDAQ:RCM).
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.